Silver Book Fact

The annual burden to the U.S. economy of age-related macular degeneration (AMD), cataract, diabetic retinopathy, glaucoma, refractive errors, visual impairment, and blindness in adults age 40 and older is estimated at $35.4 billion– $16.2 billion in direct medical costs, $11.1 billion in other direct costs, and $8 billion in lost productivity.

Rein D, Zhang P, Wirth K, Lee P, et al. The Economic Burden of Major Adult Visual Disorders in the United States. Arch Opthalmol. 2006; 124(12): 1754-60. http://archopht.ama-assn.org/cgi/content/abstract/124/12/1754

Reference

Title
The Economic Burden of Major Adult Visual Disorders in the United States
Publication
Arch Opthalmol
Publication Date
2006
Authors
Rein D, Zhang P, Wirth K, Lee P, et al
Volume & Issue
Volume 124, Issue 12
Pages
1754-60
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • The number of cases of early age-related macular degeneration (AMD) is projected to increase from 9.1 million in 2010 to 17.8 million in 2050.  
  • An estimated 83,563 Americans ages 40-49 have vision impairment. That grows to 297,754 at ages 75-79 and close to 2 million for ages 80+.  
  • One-third of age-related macular degeneration (AMD) patients suffer from clinical depression.  
  • Every 7 minutes, someone in the United States becomes blind or visually impaired.  
  • An estimated 1.75 million Americans age 40 and older have advanced age-related macular degeneration (AMD). Another 7.3 million are at substantial risk for vision loss from AMD.